Exact Mass: 306.1175
Exact Mass Matches: 306.1175
Found 319 metabolites which its exact mass value is equals to given mass value 306.1175
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cimitin
Cimifugin is an oxacycle and an organic heterotricyclic compound. Cimifugin is a natural product found in Eranthis cilicica, Ostericum grosseserratum, and other organisms with data available. Cimifugin (Cimitin) is a bioactive component of Cimicifuga racemosa, a Chinese herb. Cimifugin suppresses allergic inflammation by reducing epithelial derived initiative key factors via regulating tight junctions[1]. Cimifugin reduces the migration and chemotaxis of RAW264.7 cells and inhibits the release of inflammatory factors and activation of MAPKs and NF-κB signaling pathways induced by LPS[2]. Cimifugin (Cimitin) is a bioactive component of Cimicifuga racemosa, a Chinese herb. Cimifugin suppresses allergic inflammation by reducing epithelial derived initiative key factors via regulating tight junctions[1]. Cimifugin reduces the migration and chemotaxis of RAW264.7 cells and inhibits the release of inflammatory factors and activation of MAPKs and NF-κB signaling pathways induced by LPS[2].
Z-Gly-Pro
KEIO_ID Z003; [MS3] KO009084 KEIO_ID Z003; [MS2] KO009083 KEIO_ID Z003
(1aalpha,2beta,3alpha,11calpha)-1a,2,3,11c-Tetrahydro-6,11-dimethylbenzo[6,7]phenanthro[3,4-b]oxirene-2,3-diol
(1aalpha,2beta,3alpha,11calpha)-1a,2,3,11c-Tetrahydro-6,11-dimethylbenzo[6,7]phenanthro[3,4-b]oxirene-2,3-diol is considered to be practically insoluble (in water) and relatively neutral
trans-O-Methylgrandmarin
trans-O-Methylgrandmarin is found in citrus. trans-O-Methylgrandmarin is a constituent of satsuma mandarins (Citrus unshiu). Constituent of satsuma mandarins (Citrus unshiu). trans-O-Methylgrandmarin is found in citrus.
6-O-Desmethyl-mycophenolic acid
6-O-Desmethyl-mycophenolic acid is a metabolite of mycophenolic acid. Mycophenolic acid or mycophenolate is an immunosuppressant drug used to prevent rejection in organ transplantation. It inhibits an enzyme needed for the growth of T cells and B cells. It was initially marketed as the prodrug mycophenolate mofetil (MMF) to improve oral bioavailability. More recently, the salt mycophenolate sodium has also been introduced. Mycophenolic acid is commonly marketed under the trade names CellCept and Myfortic. (Wikipedia)
Metioprim
C254 - Anti-Infective Agent > C258 - Antibiotic
5-(Hydroxymethyl)-6-(3,5-dimethoxy-4-hydroxyphenyl)-8-oxabicyclo[3.2.1]octa-3-ene-2-one
7-(3-Methylbut-2-enyloxy)flavone|7-(3-methyl-but-2-enyloxy)-2-phenyl-chromen-4-one|7-gamma,gamma-dimethylallyloxyflavanone|Cordoin-flavon
8alpha-acetoxy-3alpha,4alpha-epoxy-1alpha-hydroxyguai-9,11(13)-dien-6alpha,12-olide
1,7,8,9-Tetrahydro-1,9-dihydroxy-4-methoxy-5-methyl-8-(1-methylethenyl)-3H-furo[3,4-f][1]benzopyran-3-one
(2S)-5-hydroxy-2-(1-hydroxy-4-oxocyclohexyl)-7-methoxychroman-4-one|(2S)-ongokein-4-one
(2E,6E)-8-(2,4,5-trihydroxyphenyl)-2,6-dimethyl-8-oxo-2,6-dienoic acid|orirubenone B
Methyl 5-acetoxymethanol-7-hydroxy-2,2-dimethyl-2H-1-chromene-6-carboxylate|methyl 5-acetoxymethyl-7-hydroxy-2,2-dimethyl-2H-1-chromene-6-carboxylate
plectranthon A|Plectranthon A ( = 3-Hydroxy-5,7,8-trimethyl-2-(prop-2-enyl)phenanthren-1,4-dion)|Plectranthone A
1,4,6-trihydroxy-2-methoxy-7-methyl-5,6,8,8a,9,10a-hexahydro-7,9-epoxyanthracen-10-one|fusaquinon A
2,3-Dihydro-3,9-dihydroxy-4-phenyl-5-methoxy-1H-phenalene
plectranthon D|Pseudoplectranthon D ( = 3-Hydroxy-7,8,10-trimethyl-2-(prop-2-enyl)phenanthren-1,4-dion)
(E)-1-(5-hydroxy-2,2-dimethyl-2H-chromen-6-yl)-3-phenylprop-2-en-1-one|1-(5-Hydroxy-2,2-dimethyl-2H-chromen-6-yl)-3t-phenyl-propenon|1-(5-hydroxy-2,2-dimethyl-2H-chromen-6-yl)-3t-phenyl-propenone|Lonchocarpin|lonchocarpine
(-)-erythro-6-(1,2-dihydroxy-3-methylbut-3-enyl)-7,8-dimethoxy-[2H]-chromen-2-one|(-)-fatouain A
nigerapyrone A
A member of the class of 2-pyranones that is 2H-pyran-2-one substituted by a methoxy group at position 4 and a 4,6-dimethylbiphenyl-2-yl group at position 6. It has been isolated from an endophytic fungus, Aspergillus niger.
3-hydroxy-1-keto-3-methyl-8-methoxy-1,2,3, 4-tetrahydro-benz[alpha]anthracene
(+)-fatouain E|(+)-threo-8-hydroxy-6-(2-hydroxy-1-methoxy-3-methylbut-3-enyl)-7-methoxy-[2H]-chromen-2-one
6-(2,3-Dihydroxy-3-methylbutyl)-7-acetoxy-2H-1-benzopyran-2-one
(S)-2,5,7-trihydroxy-3-(5-hydroxyhexyl)-1,4-naphthoquinone
(1R)-2,3-dihydro-4,9-dihydroxy-8-methoxy-1-phenylphenalene|2,3-dihydro-4,9-dihydroxy-8-methoxy-1-phenylphenalene
2-(2-Hydroxypentyl)-4-oxo-7-methoxy-4H-1-benzopyran-5-carboxylic acid
(+/-)-6-(1-ethoxyethyl)-5-hydroxy-2,7-dimethoxynaphthoquinone|6-(1-Ethoxyethyl)-5-hydroxy-2,7-dimethoxy-1,4-naphthoquinone
2-(hydroxymethyl)-6-naphthalen-2-yloxyoxane-3,4,5-triol
5-(3-hydroxy-4,5-dimethoxyphenyl)-2,3-dimethoxyphenol
(E)-1-(5-hydroxy-2,2-dimethylchromen-6-yl)-3-phenylprop-2-en-1-one
Cimifugin
Cimifugin (Cimitin) is a bioactive component of Cimicifuga racemosa, a Chinese herb. Cimifugin suppresses allergic inflammation by reducing epithelial derived initiative key factors via regulating tight junctions[1]. Cimifugin reduces the migration and chemotaxis of RAW264.7 cells and inhibits the release of inflammatory factors and activation of MAPKs and NF-κB signaling pathways induced by LPS[2]. Cimifugin (Cimitin) is a bioactive component of Cimicifuga racemosa, a Chinese herb. Cimifugin suppresses allergic inflammation by reducing epithelial derived initiative key factors via regulating tight junctions[1]. Cimifugin reduces the migration and chemotaxis of RAW264.7 cells and inhibits the release of inflammatory factors and activation of MAPKs and NF-κB signaling pathways induced by LPS[2].
C16H18O6_3H-Oxireno[h][3]benzoxacyclododecin-7,13(2H,8H)-dione, 1a,4,5,13a-tetrahydro-10,12-dihydroxy-5-methyl
15,17-dihydroxy-9-methyl-4,10-dioxatricyclo[11.4.0.0³,⁵]heptadeca-1(17),13,15-triene-2,11-dione
15,17-dihydroxy-9-methyl-4,10-dioxatricyclo[11.4.0.0³,⁵]heptadeca-1(17),13,15-triene-2,11-dione_major
15,17-dihydroxy-9-methyl-4,10-dioxatricyclo[11.4.0.0³,?]heptadeca-1(17),13,15-triene-2,11-dione
Gly Gly Ser Ser
Gly Ser Gly Ser
Gly Ser Ser Gly
Ser Gly Gly Ser
Ser Gly Ser Gly
Ser Ser Gly Gly
trans-O-Methylgrandmarin
3-AMINO-8-BENZYL-8-AZABICYCLO[3.2.1]OCTANE DIHYDROCHLORIDE MONOHYDRATE (3-ENDO)-
ethyl 4-hydroxy-5,6,8-trimethoxynaphthalene-2-carboxylate
Potassium (4-tert-butoxycarbonylpiperazin-1-yl)methyltrifluoroborate
1-[2-(4-methoxyphenyl)ethyl]piperidin-4-amine,dihydrochloride
7-Hydroxy-6-methoxy-3-[(pivaloyloxy)methyl]-3,4-dihydroquinazolin-4-one
3-methoxy-6-methyl-1-(3,4,5-trimethoxyphenyl)pyridazin-4-one
Ethyl 4-hydroxy-1-(2-methoxyethyl)-7-methyl-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylate
4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid
N-(3-PHENYL-4,5,6,7-TETRAHYDROBENZO[D]THIAZOL-2(3H)-YLIDENE)ANILINE
5-(N-TERT-BUTOXYCARBONYLAMINOMETHYL)-4-PHENYL-1,2,4-TRIAZOLE-3-THIOL
[5,5-Biisobenzofuran]-1,1,3,3-tetrone, dodecahydro-
(2R,5S)-5-Benzyl-3-methyl-2-(5-methylfuran-2-yl)imidazolidin-4-one Hydrochloride
4H-1,4-BENZODIAZEPINE-4,8-DICARBOXYLIC ACID-1,2,3,5-TETRAHYDRO-2-OXO-4-(1,1-DIMETHYLETHYL) ESTER
1-(5-Tert-butyl-2-methyl-2H-pyrazol-3-YL)-3-(4-chloro-phenyl)-urea
N-cyano-N-propan-2-ylcarbamimidothioic acid [2-(2-methoxyanilino)-2-oxoethyl] ester
15,17-Dihydroxy-9-methyl-4,10-dioxatricyclo[11.4.0.03,5]heptadeca-1(13),14,16-triene-2,11-dione
4-(4-nitrophenyl)-N-prop-2-enyl-1-piperazinecarbothioamide
N-[4-[2-(2-methoxyethylamino)-6H-1,3,4-thiadiazin-5-yl]phenyl]acetamide
1-(2,3-Dihydroindol-1-yl)-2-(5-pyridin-4-yl-2-tetrazolyl)ethanone
2-(1,3-benzodioxol-5-yl)-N-(3-pyridinylmethyl)-4-pyrimidinamine
2,3-Dihydroindol-1-yl-(6-fluoro-2-methyl-4-quinolinyl)methanone
2-(2-furanyl)-5-methyl-6-(phenylmethyl)-1H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one
3-(4-Fluorophenyl)-5-(2-furanyl)-2-phenyl-3,4-dihydropyrazole
(3S)-4-oxo-3-phenyl-3-propan-2-yldiazetidine-1,2-dicarboxylic acid dimethyl ester
5-(3-Hydroxy-4,5-dimethoxyphenyl)-2,3-dimethoxyphenol
8-(3-Phenylpropenoyl)-2,2-dimethyl-2H-1-benzopyran-7-ol
(2S,3R,4S)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2S,3S,4S)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2S,3S,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)azetidine-2-carbonitrile
(2R,3R,4S)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
2-[(2R,3R,6S)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
(2R,3S,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
2-[(2S,3R,6S)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
2-[(2R,3S,6R)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
2-[(2S,3S,6R)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
2-[(2S,3S,6S)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
2-[(2R,3R,6R)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
(2S,3R,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2R,3R,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
2-amino-7-[4-hydroxy-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-4-oxo-3H-pyrrolo[2,3-d]pyrimidine-5-carboximidamide
(1aalpha,2beta,3alpha,11calpha)-1a,2,3,11c-Tetrahydro-6,11-dimethylbenzo[6,7]phenanthro[3,4-b]oxirene-2,3-diol
1-naphthyl beta-D-glucoside
A beta-D-glucoside that is beta-D-glucopyranose in which the anomeric hydroxy hydrogen has been replaced by a 1-naphthyl group.
Facinicline (hydrochloride)
Facinicline hydrochloride (RG3487 hydrochloride) is an orally active nicotinic α7 receptor partial agonist, with a Ki of 6 nM for α7 human nAChR. Facinicline hydrochloride (RG3487 hydrochloride) improves cognition and sensorimotor gating in rodents. Facinicline hydrochloride (RG3487 hydrochloride) shows high affinity (antagonist) to 5-HT3Rs with a Ki value of 1.2 nM[1].
ML353
ML353 is a selective ligand of mGlu5 silent allosteric modulator (SAM) with an Ki value of 18.2 nM. ML353 improves the affinity of common allosteric sites, 20-fold higher than the previous mGlu5 SAM tool compound 5mpep. ML353 has potential applications in solving the intrinsic activity of SAM in vivo or as a agent blocker[1]. ML353 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
10-hydroxy-9-methyl-5-methylidene-4-oxo-3,13-dioxatetracyclo[8.4.0.0²,⁶.0¹²,¹⁴]tetradec-8-en-7-yl acetate
9-hydroxy-5,10-dimethoxy-8,8-dimethyl-9h,10h-pyrano[2,3-h]chromen-2-one
5-hydroxy-3-[(2s)-2-hydroxypropyl]-6,8-dimethoxy-2-methylnaphthalene-1,4-dione
(3s,12s,13s)-3,13-dihydroxy-7-methoxy-8-methyl-12-(prop-1-en-2-yl)-4,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-trien-5-one
2-(1,4-dihydroxycyclohexyl)-5-hydroxy-7-methoxychromen-4-one
(1s,2s,4s,5s,6r,10r)-10-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-5-yl benzoate
3-[2-(2,5-dihydroxyphenyl)-2-oxoethyl]-3-hydroxy-6-(prop-1-en-2-yl)oxan-2-one
[(5s)-5-[(2r)-2-methoxy-5-oxopyrrolidin-1-yl]-2,5-dihydrofuran-3-yl]methyl 1h-pyrrole-2-carboxylate
(1s,2s,6r,7s,10s,12r,14s)-10-hydroxy-9-methyl-5-methylidene-4-oxo-3,13-dioxatetracyclo[8.4.0.0²,⁶.0¹²,¹⁴]tetradec-8-en-7-yl acetate
(3r,3ar,4r,6s)-3-(furan-3-yl)-6-hydroxy-3a,7-dimethyl-1-oxo-3,4,5,6-tetrahydro-2-benzofuran-4-yl acetate
(9r,10s)-9-hydroxy-5,10-dimethoxy-8,8-dimethyl-9h,10h-pyrano[2,3-h]chromen-2-one
(3s,5r,9s)-15,17-dihydroxy-9-methyl-4,10-dioxatricyclo[11.4.0.0³,⁵]heptadeca-1(17),13,15-triene-2,11-dione
1-(5-hydroxy-2,2-dimethylchromen-6-yl)-3-phenylprop-2-en-1-one
methyl 2-[(4s,6s,9z,10r)-6-methyl-8,12-dioxo-5,11-dioxatricyclo[8.2.1.0⁴,⁶]tridec-1(13)-en-9-ylidene]propanoate
3-(furan-3-yl)-6-hydroxy-3a,7-dimethyl-1-oxo-3,4,5,6-tetrahydro-2-benzofuran-4-yl acetate
1-naphthol-β-d-glucopyranoside
{"Ingredient_id": "HBIN002826","Ingredient_name": "1-naphthol-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C16H18O6","Ingredient_Smile": "C1=CC=C2C(=C1)C=CC=C2OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15246","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2s)-ongokein-4'-one
{"Ingredient_id": "HBIN006819","Ingredient_name": "(2s)-ongokein-4'-one","Alias": "NA","Ingredient_formula": "C16H18O6","Ingredient_Smile": "COC1=CC(=C2C(=O)CC(OC2=C1)C3(CCC(=O)CC3)O)O","Ingredient_weight": "306.31 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16087","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101763963","DrugBank_id": "NA"}
6-(2',3'-dihydroxy-3'-methylbutyl)-7-acetoxy-2h-1-benzopyran-2-one
{"Ingredient_id": "HBIN012009","Ingredient_name": "6-(2',3'-dihydroxy-3'-methylbutyl)-7-acetoxy-2h-1-benzopyran-2-one","Alias": "NA","Ingredient_formula": "C16H18O6","Ingredient_Smile": "CC(=O)OC1=C(C=C2C=CC(=O)OC2=C1)CC(C(C)(C)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6025","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8-(3-hydroxy-3-methylbutanoyl)-5,7-dimethoxycoumarin
{"Ingredient_id": "HBIN013567","Ingredient_name": "8-(3-hydroxy-3-methylbutanoyl)-5,7-dimethoxycoumarin","Alias": "NA","Ingredient_formula": "C16H18O6","Ingredient_Smile": "NA","Ingredient_weight": "306.31","OB_score": "NA","CAS_id": "75239-74-6","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7412","PubChem_id": "NA","DrugBank_id": "NA"}